본문 바로가기
KERD
논문KCI 등재

AMH 수치가 상승된 희발월경 환자 증례보고

A Case Study on Korean Medicine Treatment for the Oligomenorrhea with Increased Anti-mullerian Hormone Level

강수진|김선경|김송백|홍가경
대한한방부인과학회 (The Society Of Oriental Obstetrics & Gynecology)|2018.08|대한한방부인과학회지 (The Journal of Oriental Obstetrics ＆ Gynecology)|제31권 제3호|pp. 152-163|DOI https://doi.org/10.15204/jkobgy.2018.31.3.152

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

Korean Medicine TherapyOligomenorrheaAnti-mullerian HormonePCOS(Polycystic Ovarian Syndrome)
주제분류한의학

초록

Objectives: In recent studies, increased AMH level has been suggested as objective surrogate marker for diagnosis PCOS, one of the major causes of oligomenorrhea. The purpose of this study is to report the clinical effect of Korean medicine treatment on oligomenorrhea patient with increased Anti-mullerian hormone level, who can be diagnosed who can be ruled out PCOS. Methods: A 27 year old woman with oligomenorrhea was enrolled in this study. We measured serum hormone levels and ruled out PCOS. The patient received Korean medicine treatment for 3 months, we assessed the result of treatment through observation of the menstrual cycle and follow-up measurements of serum hormone levels. Results: 1. The patient had menstrual cycle regularly. 2. Increased serum AMH level of the patient decreased from 12.16 ng/ml to 8.51 ng/ml. 3. The other serum hormone levels such as testosterone, LH/FSH ratio decreased Conclusion: This case shows that Korean medicine treatment could have a beneficial effect on menstrual cycle and decrease the increased serum hormone levels of ruled out PCOS patient

Abstract

Objectives: In recent studies, increased AMH level has been suggested as objective surrogate marker for diagnosis PCOS, one of the major causes of oligomenorrhea. The purpose of this study is to report the clinical effect of Korean medicine treatment on oligomenorrhea patient with increased Anti-mullerian hormone level, who can be diagnosed who can be ruled out PCOS. Methods: A 27 year old woman with oligomenorrhea was enrolled in this study. We measured serum hormone levels and ruled out PCOS. The patient received Korean medicine treatment for 3 months, we assessed the result of treatment through observation of the menstrual cycle and follow-up measurements of serum hormone levels. Results: 1. The patient had menstrual cycle regularly. 2. Increased serum AMH level of the patient decreased from 12.16 ng/ml to 8.51 ng/ml. 3. The other serum hormone levels such as testosterone, LH/FSH ratio decreased Conclusion: This case shows that Korean medicine treatment could have a beneficial effect on menstrual cycle and decrease the increased serum hormone levels of ruled out PCOS patient

참고문헌 (26)

  1. Korean Society of Obstetrics and Gynecology, "Gynecology", pp.81~493 (2015), Korea Medical Book Publishing Company
  2. The society of Korean medicine obstetrics and gynecology, "Korean medicine obstetrics and gynecology", pp.31~191 (2016), Uiseongdang
  3. 김진환, "정상월경군과 희발월경군의 BMI, 양도락, 초경연령 비교를 통한 희발월경 환자의 특성 연구", 대한한방부인과학회지, 24(3), pp.85~97 (2011), 대한한방부인과학회
  4. Lee HY, "Epidemiology and Diagnostic Criteria of Polycystic Ovary Syndrome", J Korean Diabetes, 16(3), pp.189~193 (2015)[DOI]
  5. 유시연, "다낭성 난소증후군의 항뮐러관 호르몬에 관한 연구", Obstetrics & Gynecology Science, 55(05), pp.315~324 (2012), 대한산부인과학회[DOI]
  6. Dumont A, "Role of Anti-Mullerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review", Reproductive Biology and Endocrinology, 13(1), pp.137~ (2015)[DOI]
  7. 송도경, "Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value", The Korean Journal of Internal Medicine, 32(4), pp.690~698 (2017), 대한내과학회[DOI]
  8. Dewailly D, "Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Mullerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism", J Clin Endocrinol Metab, 95(9), pp.4399~4405 (2010)[DOI]
  9. Sung YH, "Medical Diagnosis and Treatment of Polycystic Ovary Syndrome", The Korean Journal of Medicine, 70(4), pp.356~360 (2006)
  10. Balen A, "Polycystic Ovary Syndrome: the spectrum of the disorder in 1741 patients", Hum Reprod, 10(8), pp.2107~2111 (1995)[DOI]
  11. Sirmans SM, "Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome", Clinical Epidemiology, 6, pp.1~13 (2013)
  12. 성연아, "한국여성의 다낭난소증후군: 임상 특징과 진단기준", Endocrinology and Metabolism, 26(3), pp.203~207 (2011), 대한내분비학회
  13. Fauser B, "Consensus on Women's Health Aspects of Polycystic Ovary Syndrome(PCOS): the Amsterdam ESHRE", ASRM-sponsored 3rd PCOS Consensus Workshop Group, 2012, pp.97(1), 28~38.e25
  14. Yun SY, "Clinical Study of Oriental Medicine Treatment for Polycystic Ovarian Disease", The Journal Of Oriental Obstetrics & Gynecology, 13(2), pp.437~451 (2000)
  15. Bili H., "Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years", Eur J Endocrinol, 145(6), pp.749~755 (2001)[DOI]
  16. Moran C, "Adrenal androgen excess and body mass index in polycystic ovary syndrome", J Clin Endocrinol Metab, 100(3), pp.942~950 (2015)[DOI]
  17. 이정렬, "여성 생식에서 Anti-Müllerian Hormone의 역할", Obstetrics & Gynecology Science, 52(3), pp.285~300 (2009), 대한산부인과학회
  18. La Marca A, "Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics", Fertil Steril, 82(4), pp.970~972 (2004)[DOI]
  19. Pigny P, "Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome", J Clin Endocrinol Metab, 91(3), pp.941~945 (2006)[DOI]
  20. Li L, "Elevated serum antimullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome", Wien Klin Wochenschr, 122(17-18), pp.519~524 (2010)[DOI]
  21. Woo HY, "Differences of the association of anti-Mullerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome", Endocr J, 59(9), pp.781~790 (2012)[DOI]
  22. Mun JB, "Usefulness of Anti-mullerian Hormone for the Diagnosis of Polycystic Ovary Syndrome" (2014)
  23. Seopgye(葉桂), "Seopcheonsayeogwa(葉天士女科)", pp.14~15 (1995), Daeseongmunhwasa
  24. Shin MK, "Clinical Traditional Herbalogy", pp.213~558 (2010), Youngrimsa
  25. 오탁근, "다낭성 난소증후군 치험1례", 대한한방부인과학회지, 21(2), pp.284~291 (2008), 대한한방부인과학회
  26. 김지양, "호르몬검사를 이용하여 관찰한 속발성무월경 및 과소월경의 치험 4례", 대한한방부인과학회지, 22(3), pp.267~276 (2009), 대한한방부인과학회

관련 논문AI추천

혈중 항뮬러관호르몬 저하를 진단 받은 난임 환자의 한방치료 후 임신 4례문현주, 조현주대한한방부인과학회 · 대한한방부인과학회지2015 · 제28권 제2호혈중 항뮬러관호르몬 저하를 진단받은 난임 환자의 한방치료 후 자연임신 2례와 항뮬러관호르몬의 상승 2례정소영, 최용주대한한방부인과학회 · 대한한방부인과학회지2016 · 제29권 제1호난소기능저하 미혼여성의 난자동결보존시 한약복용을 병행한 증례보고고지은, 유명숙대한한방부인과학회 · 대한한방부인과학회지2019 · 제32권 제2호다낭성 난소증후군 치험 1례김지예, 정소영대한한방부인과학회 · 대한한방부인과학회지2014 · 제27권 제3호한의치료로 호전된 조기난소기능부족증 환자 치험 1례 보고김동일, 최수지대한한방부인과학회 · 대한한방부인과학회지2019 · 제32권 제4호한방 치료로 고안드로겐혈증을 개선한 다낭성 난소 증후군 연속증례연구김남권, 배지용, 신혜규, 안해인, 윤영흠, 지영근대한한방부인과학회 · 대한한방부인과학회지2021 · 제34권 제3호

이 간행물의 다른 논문 (12건)

산후 우울증의 한방 치료에 대한 무작위대조군연구 중심의 연구 동향이진무, 박경선, 장준복, 최석영, 이창훈, 황덕상pp. 1-19진균성 질염의 한약 훈증 치료에 대한 체계적 문헌 고찰배주은, 윤영진, 박경덕pp. 20-32다낭성난소증후군 변증도구와 생체지표 간의 상관성 연구박은지, 백선은, 유정은, 강병갑, 정인철pp. 33-49만성 골반통 여성의 한의학적 치료에 관한 국내 임상 연구 고찰소민지, 이윤재, 문혜연, 유옥철, 최성률pp. 50-60한방병원에 산후병으로 내원한 산모의 특성 및 증상에 대한 분석이진욱, 장준복, 이진무, 황영식, 박남춘, 박승혁, 황덕상, 양혜린, 이창훈pp. 61-78
원문 보기